The Phenotype of Recovery XI: Associations of Sleep Quality and Perceived Stress with Discounting and Quality of Life in Substance Use Recovery

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2024 Mar 20

PMID 38504067

Authors

Yu-Hua Yeh

Michelle H Zheng

Allison N Tegge

Liqa N Athamneh

Roberta Freitas-Lemos

Candice L Dwyer

Warren K Bickel

Affiliations

Soon will be listed here.

Abstract

Purpose: Sleep and stress show an interdependent relationship in physiology, and both are known risk factors for relapse in substance use disorder (SUD) recovery. However, sleep and stress are often investigated independently in addiction research. In this exploratory study, the associations of sleep quality and perceived stress with delay discounting (DD), effort discounting (ED), and quality of life (QOL) were examined concomitantly to determine their role in addiction recovery. DD has been proposed as a prognostic indicator of SUD treatment response, ED is hypothesized to be relevant to the effort to overcome addiction, and QOL is an important component in addiction recovery.

Method: An online sample of 118 individuals recovering from SUDs was collected through the International Quit and Recovery Registry. Exhaustive model selection, using the Bayesian Information Criterion to determine the optimal multiple linear model, was conducted to identify variables (i.e., sleep quality, perceived stress, and demographics) contributing to the total variance in DD, ED, and QOL.

Results: After model selection, sleep was found to be significantly associated with DD. Stress was found to be significantly associated with psychological health, social relationships, and environment QOL. Both sleep and stress were found to be significantly associated with physical health QOL. Neither sleep nor stress was supported as an explanatory variable of ED.

Conclusion: Together, these findings suggest sleep and stress contribute uniquely to the process of addiction recovery. Considering both factors when designing interventions and planning for future research is recommended.

References

Andersson H, Wenaas M, Nordfjaern T . Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances. Addict Behav. 2018; 90:222-228. DOI: 10.1016/j.addbeh.2018.11.008. View

Kabisa E, Biracyaza E, Habagusenga J, Umubyeyi A . Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre. Subst Abuse Treat Prev Policy. 2021; 16(1):13. PMC: 7851925. DOI: 10.1186/s13011-021-00347-0. View

Nunes E, Gordon M, Friedmann P, Fishman M, Lee J, Chen D . Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone. J Subst Abuse Treat. 2017; 85:49-55. PMC: 5755382. DOI: 10.1016/j.jsat.2017.04.016. View

Brower K, Perron B . Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Med Hypotheses. 2009; 74(5):928-33. PMC: 2850945. DOI: 10.1016/j.mehy.2009.10.020. View

Sinha R . The role of stress in addiction relapse. Curr Psychiatry Rep. 2007; 9(5):388-95. DOI: 10.1007/s11920-007-0050-6. View

Valentino R, Volkow N . Drugs, sleep, and the addicted brain. Neuropsychopharmacology. 2019; 45(1):3-5. PMC: 6879727. DOI: 10.1038/s41386-019-0465-x. View

Fronk G, SantAna S, Kaye J, Curtin J . Stress Allostasis in Substance Use Disorders: Promise, Progress, and Emerging Priorities in Clinical Research. Annu Rev Clin Psychol. 2020; 16:401-430. PMC: 7259491. DOI: 10.1146/annurev-clinpsy-102419-125016. View

Athamneh L, Freitas Lemos R, Basso J, Tomlinson D, Craft W, Stein M . The phenotype of recovery II: The association between delay discounting, self-reported quality of life, and remission status among individuals in recovery from substance use disorders. Exp Clin Psychopharmacol. 2020; 30(1):59-72. PMC: 9843550. DOI: 10.1037/pha0000389. View

MacKillop J, Amlung M, Few L, Ray L, Sweet L, Munafo M . Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology (Berl). 2011; 216(3):305-21. PMC: 3201846. DOI: 10.1007/s00213-011-2229-0. View

10.

Sheffer C, Christensen D, Landes R, Carter L, Jackson L, Bickel W . Delay discounting rates: a strong prognostic indicator of smoking relapse. Addict Behav. 2014; 39(11):1682-1689. PMC: 4316833. DOI: 10.1016/j.addbeh.2014.04.019. View

11.

Conroy D, Arnedt J . Sleep and substance use disorders: an update. Curr Psychiatry Rep. 2014; 16(10):487. DOI: 10.1007/s11920-014-0487-3. View

12.

Roehrs T, Roth T . Sleep Disturbance in Substance Use Disorders. Psychiatr Clin North Am. 2015; 38(4):793-803. PMC: 4660250. DOI: 10.1016/j.psc.2015.07.008. View

13.

Vandrey R, Smith M, McCann U, Budney A, Curran E . Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug Alcohol Depend. 2011; 117(1):38-44. PMC: 3119729. DOI: 10.1016/j.drugalcdep.2011.01.003. View

14.

Lijffijt M, Hu K, Swann A . Stress modulates illness-course of substance use disorders: a translational review. Front Psychiatry. 2014; 5:83. PMC: 4101973. DOI: 10.3389/fpsyt.2014.00083. View

15.

Mukhara D, Banks M, Neigh G . Stress as a Risk Factor for Substance Use Disorders: A Mini-Review of Molecular Mediators. Front Behav Neurosci. 2019; 12:309. PMC: 6308626. DOI: 10.3389/fnbeh.2018.00309. View

16.

Sinha R . Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008; 1141:105-30. PMC: 2732004. DOI: 10.1196/annals.1441.030. View

17.

Arnedt J, Conroy D, Brower K . Treatment options for sleep disturbances during alcohol recovery. J Addict Dis. 2007; 26(4):41-54. PMC: 2936493. DOI: 10.1300/J069v26n04_06. View

18.

Britton W, Bootzin R, Cousins J, Hasler B, Peck T, Shapiro S . The contribution of mindfulness practice to a multicomponent behavioral sleep intervention following substance abuse treatment in adolescents: a treatment-development study. Subst Abus. 2010; 31(2):86-97. DOI: 10.1080/08897071003641297. View

19.

Garland E . Restructuring reward processing with Mindfulness-Oriented Recovery Enhancement: novel therapeutic mechanisms to remediate hedonic dysregulation in addiction, stress, and pain. Ann N Y Acad Sci. 2016; 1373(1):25-37. PMC: 4940274. DOI: 10.1111/nyas.13034. View

20.

Sellers R, Caldwell C, Schmeelk-Cone K, Zimmerman M . Racial identity, racial discrimination, perceived stress, and psychological distress among African American young adults. J Health Soc Behav. 2003; 44(3):302-17. View